Cargando…
FAM83A is amplified and promotes cancer stem cell-like traits and chemoresistance in pancreatic cancer
Cancer stem cells (CSCs), also known as tumor-initiating cells (TICs), contribute to tumorigenesis, resistance to chemoradiotherapy and recurrence in human cancers, suggesting targeting CSCs may represent a potential therapeutic strategy. In the current study, we found family with sequence similarit...
Autores principales: | Chen, S, Huang, J, Liu, Z, Liang, Q, Zhang, N, Jin, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533946/ https://www.ncbi.nlm.nih.gov/pubmed/28287611 http://dx.doi.org/10.1038/oncsis.2017.3 |
Ejemplares similares
-
miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
por: Liu, Cuiping, et al.
Publicado: (2020) -
Long noncoding antisense RNA FAM83A‐AS1 promotes lung cancer cell progression by increasing FAM83A
por: Shi, Rongxing, et al.
Publicado: (2019) -
HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
por: Bartel, Courtney A., et al.
Publicado: (2017) -
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019) -
FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)